0001437749-21-021563.txt : 20210907
0001437749-21-021563.hdr.sgml : 20210907
20210907160617
ACCESSION NUMBER: 0001437749-21-021563
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210907
DATE AS OF CHANGE: 20210907
EFFECTIVENESS DATE: 20210907
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEPHROS INC
CENTRAL INDEX KEY: 0001196298
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 133971809
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-283400
FILM NUMBER: 211239362
BUSINESS ADDRESS:
STREET 1: 380 LACKAWANNA PLACE
CITY: SOUTH ORANGE
STATE: NJ
ZIP: 07079
BUSINESS PHONE: 201.343.5202
MAIL ADDRESS:
STREET 1: 380 LACKAWANNA PLACE
CITY: SOUTH ORANGE
STATE: NJ
ZIP: 07079
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001196298
NEPHROS INC
380 Lackawanna Place
South Orange
NJ
NEW JERSEY
07079
201-343-5202
DELAWARE
None
None
Corporation
true
Andrew
Astor
380 Lackawanna Place
South Orange
NJ
NEW JERSEY
07079
Executive Officer
Director
Arthur
Amron
380 Lackawanna Place
South Orange
NJ
NEW JERSEY
07079
Director
Thomas
Gwydir
380 Lackawanna Place
South Orange
NJ
NEW JERSEY
07079
Director
Oliver
Spandow
380 Lackawanna Place
South Orange
NJ
NEW JERSEY
07079
Director
Alisa
Lask
380 Lackawanna Place
South Orange
NJ
NEW JERSEY
07079
Director
Other Health Care
Decline to Disclose
- 06b
true
0001437749-20-019341
2017-03-17
true
true
true
The underlying offering is complete and this amendment to the original Form D covers only the common stock issuable upon exercise of warrants sold in the underlying offering.
false
0
2436000
2102615
333385
The underlying offering is complete. (B) reflects common stock sold in the offering and common stock previously issued upon the exercise of warrants sold. (C) reflects common stock issuable upon the exercise of outstanding warrants sold in the offering.
false
19
0
0
The underlying offering is complete. The placement agent for such offering received warrants to purchase 9,023 shares of common stock.
100000
true
Anticipated payment of executive officer salaries.
false
NEPHROS INC
/s/ Andrew Astor
Andrew Astor
Chief Executive Officer
2021-09-07